183 related articles for article (PubMed ID: 1321494)
1. Modulation of DNA binding specificity by alternative splicing of the Wilms tumor wt1 gene transcript.
Bickmore WA; Oghene K; Little MH; Seawright A; van Heyningen V; Hastie ND
Science; 1992 Jul; 257(5067):235-7. PubMed ID: 1321494
[TBL] [Abstract][Full Text] [Related]
2. Alternative splicing and genomic structure of the Wilms tumor gene WT1.
Haber DA; Sohn RL; Buckler AJ; Pelletier J; Call KM; Housman DE
Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9618-22. PubMed ID: 1658787
[TBL] [Abstract][Full Text] [Related]
3. Products of alternatively spliced transcripts of the Wilms' tumor suppressor gene, wt1, have altered DNA binding specificity and regulate transcription in different ways.
Wang ZY; Qiu QQ; Huang J; Gurrieri M; Deuel TF
Oncogene; 1995 Feb; 10(3):415-22. PubMed ID: 7845666
[TBL] [Abstract][Full Text] [Related]
4. DNA recognition by splicing variants of the Wilms' tumor suppressor, WT1.
Drummond IA; Rupprecht HD; Rohwer-Nutter P; Lopez-Guisa JM; Madden SL; Rauscher FJ; Sukhatme VP
Mol Cell Biol; 1994 Jun; 14(6):3800-9. PubMed ID: 8196623
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional repression mediated by the WT1 Wilms tumor gene product.
Madden SL; Cook DM; Morris JF; Gashler A; Sukhatme VP; Rauscher FJ
Science; 1991 Sep; 253(5027):1550-3. PubMed ID: 1654597
[TBL] [Abstract][Full Text] [Related]
6. Expression in Xenopus oocytes shows that WT1 binds transcripts in vivo, with a central role for zinc finger one.
Ladomery M; Sommerville J; Woolner S; Slight J; Hastie N
J Cell Sci; 2003 Apr; 116(Pt 8):1539-49. PubMed ID: 12640038
[TBL] [Abstract][Full Text] [Related]
7. Sequence and structural requirements for high-affinity DNA binding by the WT1 gene product.
Nakagama H; Heinrich G; Pelletier J; Housman DE
Mol Cell Biol; 1995 Mar; 15(3):1489-98. PubMed ID: 7862142
[TBL] [Abstract][Full Text] [Related]
8. Overlapping RNA and DNA binding domains of the wt1 tumor suppressor gene product.
Bardeesy N; Pelletier J
Nucleic Acids Res; 1998 Apr; 26(7):1784-92. PubMed ID: 9512553
[TBL] [Abstract][Full Text] [Related]
9. Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1.
Borel F; Barilla KC; Hamilton TB; Iskandar M; Romaniuk PJ
Biochemistry; 1996 Sep; 35(37):12070-6. PubMed ID: 8810912
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Wilms tumor 1 transactivation by bone marrow zinc finger 2, a novel transcriptional repressor.
Lee TH; Lwu S; Kim J; Pelletier J
J Biol Chem; 2002 Nov; 277(47):44826-37. PubMed ID: 12239212
[TBL] [Abstract][Full Text] [Related]
11. WT1-mediated growth suppression of Wilms tumor cells expressing a WT1 splicing variant.
Haber DA; Park S; Maheswaran S; Englert C; Re GG; Hazen-Martin DJ; Sens DA; Garvin AJ
Science; 1993 Dec; 262(5142):2057-9. PubMed ID: 8266105
[TBL] [Abstract][Full Text] [Related]
12. RNA binding by the Wilms tumor suppressor zinc finger proteins.
Caricasole A; Duarte A; Larsson SH; Hastie ND; Little M; Holmes G; Todorov I; Ward A
Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7562-6. PubMed ID: 8755514
[TBL] [Abstract][Full Text] [Related]
13. PAX 8 regulates human WT1 transcription through a novel DNA binding site.
Fraizer GC; Shimamura R; Zhang X; Saunders GF
J Biol Chem; 1997 Dec; 272(49):30678-87. PubMed ID: 9388203
[TBL] [Abstract][Full Text] [Related]
14. A novel target for the Wilms' tumour suppressor protein (WT1) is bound by a unique combination of zinc fingers.
Little MH; Holmes G; Pell L; Caricasole A; Duarte A; Law M; Ward A; Wainwright B
Oncogene; 1996 Oct; 13(7):1461-9. PubMed ID: 8875984
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of the remaining allele of the WT1 gene in a Wilms' tumour from a WAGR patient.
Brown KW; Watson JE; Poirier V; Mott MG; Berry PJ; Maitland NJ
Oncogene; 1992 Apr; 7(4):763-8. PubMed ID: 1314370
[TBL] [Abstract][Full Text] [Related]
16. Altered trans-activational properties of a mutated WT1 gene product in a WAGR-associated Wilms' tumor.
Park S; Tomlinson G; Nisen P; Haber DA
Cancer Res; 1993 Oct; 53(20):4757-60. PubMed ID: 8402654
[TBL] [Abstract][Full Text] [Related]
17. Identification of the cellular protein encoded by the human Wilms' tumor (WT1) gene.
Telerman A; Dodemont H; Degraef C; Galand P; Bauwens S; Van Oostveldt P; Amson RB
Oncogene; 1992 Dec; 7(12):2545-8. PubMed ID: 1334252
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of Wilms tumor WT1 splice variants on the insulin receptor promoter.
Webster NJ; Kong Y; Sharma P; Haas M; Sukumar S; Seely BL
Biochem Mol Med; 1997 Dec; 62(2):139-50. PubMed ID: 9441865
[TBL] [Abstract][Full Text] [Related]
19. The WT1 Wilms tumor gene product: a developmentally regulated transcription factor in the kidney that functions as a tumor suppressor.
Rauscher FJ
FASEB J; 1993 Jul; 7(10):896-903. PubMed ID: 8393820
[TBL] [Abstract][Full Text] [Related]
20. Characterization of RNA aptamer binding by the Wilms' tumor suppressor protein WT1.
Zhai G; Iskandar M; Barilla K; Romaniuk PJ
Biochemistry; 2001 Feb; 40(7):2032-40. PubMed ID: 11329270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]